Christine Dolan - 28 Apr 2023 Form 4 Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Role
Chief Operating Officer, Biologics Safety Testing
Signature
/s/ Kurt Oreshack, by power of attorney for Christine Dolan
Issuer symbol
MRVI
Transactions as of
28 Apr 2023
Net transactions value
+$16,338
Form type
4
Filing time
19 Jul 2023, 16:51:11 UTC
Previous filing
17 Mar 2023
Next filing
16 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVI Class A Common Stock Award $16,338 +1,394 +1.9% $11.72 73,998 28 Apr 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 1,394 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

Remarks:

Chief Operating Officer, Biologics Safety Testing